![]() |
Volumn 1, Issue 3, 2000, Pages 143-145
|
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
|
Author keywords
Aspirin; Cerebral ischaemia; Clopidogrel; Myocardial infarction; Peripheral artery disease
|
Indexed keywords
ACETYLSALICYLIC ACID;
ADENOSINE DIPHOSPHATE;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
PLACEBO;
PYRIDINE DERIVATIVE;
THROMBOCYTE RECEPTOR;
TICLOPIDINE;
ARTERY DISEASE;
BRAIN ISCHEMIA;
CARDIOVASCULAR DISEASE;
CEREBROVASCULAR ACCIDENT;
CHEMOPROPHYLAXIS;
CLINICAL STUDY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DRUG EFFICACY;
DRUG SAFETY;
GASTROINTESTINAL SYMPTOM;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
ISCHEMIC HEART DISEASE;
LIVER DYSFUNCTION;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NEUTROPENIA;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
RASH;
RISK ASSESSMENT;
SECONDARY PREVENTION;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
TREATMENT OUTCOME;
|
EID: 0034467769
PISSN: 14686708
EISSN: None
Source Type: Journal
DOI: 10.1186/CVM-1-3-143 Document Type: Note |
Times cited : (6)
|
References (15)
|